These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 11238264)

  • 1. Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus.
    Rozenman Y; Sapoznikov D; Gotsman MS
    Clin Cardiol; 2000 Dec; 23(12):890-4. PubMed ID: 11129674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"?
    Ludman PF
    Heart; 2002 Sep; 88(3):213-5. PubMed ID: 12181203
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?
    Neumann FJ
    Herz; 2022 Oct; 47(5):442-448. PubMed ID: 35962199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between neutrophil-lymphocyte ratio and in-stent restenosis in superficial femoral artery.
    Yang Y; Ge F; Shen J; Song J; Xie J; Qu J; Mao X; Kuang Z; Wang X; Wu Y; Wang S; Xiao L
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32583853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a lifestyle management educational program on blood pressure, heart rate, and body mass index in patients with hypertension.
    Jafari F; Shahriari M; Sabouhi F; Khosravi-Farsani A; Eghbali-Babadi M
    ARYA Atheroscler; 2020 Jan; 16(1):7-15. PubMed ID: 32499826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAI-1 and diabetes: a journey from the bench to the bedside.
    Schneider DJ; Sobel BE
    Diabetes Care; 2012 Oct; 35(10):1961-7. PubMed ID: 22996180
    [No Abstract]   [Full Text] [Related]  

  • 7. Choosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decision.
    Rocha AS; Dutra P; Lorenzo AD
    Curr Cardiol Rev; 2010 Nov; 6(4):333-6. PubMed ID: 22043209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bypass surgery with drug-eluting stents in diabetic patients with left main coronary stenosis.
    Zhao X; Zhou Y; Song H; Guan L; Zheng G; Jin Z; Shi D; Li Y; Guo Y; Shi GP; Cheng XW
    Yonsei Med J; 2011 Nov; 52(6):923-32. PubMed ID: 22028155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle.
    Tammali R; Saxena A; Srivastava SK; Ramana KV
    Endocrinology; 2010 May; 151(5):2140-50. PubMed ID: 20308528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Care of patients after coronary stent implantation: what is important in practice?].
    Schächinger V
    Internist (Berl); 2007 Dec; 48(12):1365-74. PubMed ID: 17992495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus and coronary artery disease--a high risk combination].
    Schächinger V; Britten MB; Zeiher AM
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i18-26. PubMed ID: 16598543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.
    Srivastava S; Ramana KV; Tammali R; Srivastava SK; Bhatnagar A
    Diabetes; 2006 Apr; 55(4):901-10. PubMed ID: 16567509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Debate: PCI or CABG for multivessel disease? Viewpoint: No clear winner in an unfair fight.
    Bhatt DL; Topol EJ
    Curr Control Trials Cardiovasc Med; 2001; 2(6):260-262. PubMed ID: 11806809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty.
    Van Belle E; Ketelers R; Bauters C; Périé M; Abolmaali K; Richard F; Lablanche JM; McFadden EP; Bertrand ME
    Circulation; 2001 Mar; 103(9):1218-24. PubMed ID: 11238264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.
    Van Belle E; Bauters C; Hubert E; Bodart JC; Abolmaali K; Meurice T; McFadden EP; Lablanche JM; Bertrand ME
    Circulation; 1997 Sep; 96(5):1454-60. PubMed ID: 9315531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
    Kip KE; Faxon DP; Detre KM; Yeh W; Kelsey SF; Currier JW
    Circulation; 1996 Oct; 94(8):1818-25. PubMed ID: 8873655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients.
    Van Belle E; Abolmaali K; Bauters C; McFadden EP; Lablanche JM; Bertrand ME
    J Am Coll Cardiol; 1999 Aug; 34(2):476-85. PubMed ID: 10440162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty.
    St Claire DA; King SB
    Coron Artery Dis; 1996 Oct; 7(10):744-52. PubMed ID: 8970765
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.